NEW YORK (CNNMoney) -- StockTwits was all about technology and drug stocks Friday, with tweets paying particular attention to Micron Technology, Oracle, and Pain Therapeutics.
Micron's (Fortune 500) third-quarter sales and profit came in below analysts estimates, sending shares 13% lower Friday. The chip maker's stocks was the worst performer on the S&P 500 ( ) and Nasdaq Composite ( ).,
Oracle's (Fortune 500) quarterly results also disappointed investors. While the company's overall profit and revenues rose and beat expecations, Oracle's hardware sales fell 6% - far short of what the company had predicted.,
Drug companies were also a hot topic.
The Food and Drug Administration rejected an application from Pfizer (Fortune 500) and Pain Therapeutics ( ) for Remoxy, a pain medication that is designed to reduce abuse using Durect Corp.'s ( ) technology.,
All of that is giving StockTwits users plenty to tweet about:
|Apple set for showdown on Capitol Hill over corporate taxes|
|Why I'm protesting against Gap over Bangladesh|
|The biggest merger you didn't hear about today|
|Tesla's fight with America's car dealers|
|Overnight Avg Rate||Latest||Change||Last Week|
|30 yr fixed||3.67%||3.62%|
|15 yr fixed||2.80%||2.76%|
|30 yr refi||3.65%||3.61%|
|15 yr refi||2.80%||2.76%|
Today's featured rates: